AU6046198A - Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines - Google Patents

Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines

Info

Publication number
AU6046198A
AU6046198A AU60461/98A AU6046198A AU6046198A AU 6046198 A AU6046198 A AU 6046198A AU 60461/98 A AU60461/98 A AU 60461/98A AU 6046198 A AU6046198 A AU 6046198A AU 6046198 A AU6046198 A AU 6046198A
Authority
AU
Australia
Prior art keywords
rhea
emu
vaccines
birds
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60461/98A
Inventor
Kenneth Hoyt
Paul Lemley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6046198A publication Critical patent/AU6046198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
AU60461/98A 1997-01-31 1998-01-30 Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines Abandoned AU6046198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3676797P 1997-01-31 1997-01-31
US60036767 1997-01-31
PCT/US1998/001587 WO1998033474A1 (en) 1997-01-31 1998-01-30 Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines

Publications (1)

Publication Number Publication Date
AU6046198A true AU6046198A (en) 1998-08-25

Family

ID=21890528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60461/98A Abandoned AU6046198A (en) 1997-01-31 1998-01-30 Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines

Country Status (2)

Country Link
AU (1) AU6046198A (en)
WO (1) WO1998033474A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
EP1212093B1 (en) 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
US6951658B1 (en) 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
EP1917976B1 (en) * 2005-08-01 2011-03-16 Hisamitsu Pharmaceutical Co. Inc. Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
EP2838521A4 (en) 2012-04-16 2015-03-11 Zemtsov Entpr Llc Formulations and methods for treatment of wounds and inflammatory skin conditions
US9993549B2 (en) 2013-10-31 2018-06-12 Hisamitsu Pharmaceutical Co., Inc. Adjuvant composition, adjuvant preparation containing same, and kit
WO2017048807A1 (en) 2015-09-17 2017-03-23 Jrx Biotechnology, Inc. Approaches for improving skin hydration or moisturization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3172177B2 (en) * 1990-11-14 2001-06-04 イミュー プロダクツ ウェスターン オーストレイリア ピーティーワイ． リミテッド Anti-flame mixtures derived from emu oil
US5747659A (en) * 1994-02-28 1998-05-05 Agritech Technologies, Ltd. Fusion gene products encoding avian alpha subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein
US5472713A (en) * 1994-11-23 1995-12-05 Elf Resources, Inc. Therapeutic uses of emu oil
US5744128A (en) * 1995-05-03 1998-04-28 Holick; Michael F. Use of emu oil for stimulating skin and hair growth

Also Published As

Publication number Publication date
WO1998033474A1 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
AU7493398A (en) Pulsatile drug delivery system
AU6075198A (en) Drug delivery system for two or more active substances
AU6140598A (en) Multipathway electronically-controlled drug delivery system
AU5343899A (en) Catheter drug delivery system and method for use
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
IL110024A0 (en) Protein drugs delivery system
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HK1020949A1 (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
AU3028897A (en) New guanidine derivatives, methods of preparing them, and their use as drugs
SI0771788T1 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
AU7201998A (en) Drug delivery system
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
EP0960885A4 (en) Depsipeptides and drugs containing the same as the active ingredient
AU6046198A (en) Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
ZA971746B (en) Taxoids, their preparation and pharmaceutical compositions containing them.
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
AU5539798A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
WO2001005414A8 (en) Algae protein polysaccharide extraction and use thereof
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs
EP0967222A4 (en) Cyclic depsipeptides and drugs containing the same as the active ingredient
HRP980527B1 (en) Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them